Physician

Jijun Liu, MD

According to 2025 Medicare claims, Jijun Liu, MD (NPI: 1043474042) practices medical oncology in the Peoria, IL market, with the plurality of this provider's patient population coming from Peoria, IL. This provider's primary affiliated billing organization is ONCOLOGY-HEMATOLOGY ASSOCIATES OF CENTRAL ILLINOIS P C (NPI: 1801896063; TIN: 371331017) and primary practice location at 61615-7822. Liu is affiliated with the IRCCO (ACO ID: A2619), participating under the MSSP model.

Liu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,247 traditional Medicare patients, billed 378,284 HCPCS/CPT codes, and received $6,271,076 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,578 prescription claims across 405 beneficiaries totaling $6,953,743 in drug costs, led by Lenalidomide (Lenalidomide). 2022 DME data shows 12 claims. Open Payments data shows 1 records totaling $131. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,939,615 to $6,271,076. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $2,041,746 to $6,953,743. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $8,326 to $1,131.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.1M$6.3M2015 Medicare payment: $2,939,615 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,586,781 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $4,519,822 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $4,363,439 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $4,865,197 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $4,412,692 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $5,296,775 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,547,306 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,972,167 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $6,271,076 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,521210,756$2,939,615
20161,407209,238$2,586,781
20171,567339,485$4,519,822
20181,522329,789$4,363,439
20191,572320,299$4,865,197
20201,418281,946$4,412,692
20211,434347,810$5,296,775
20221,293359,604$4,547,306
20231,200294,564$3,972,167
20241,247378,284$6,271,076

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.5M$7.1M2015 Drug cost: $2,041,746 (USD; Tot_Drug_Cst)2016 Drug cost: $2,862,723 (USD; Tot_Drug_Cst)2017 Drug cost: $3,497,528 (USD; Tot_Drug_Cst)2018 Drug cost: $2,689,742 (USD; Tot_Drug_Cst)2019 Drug cost: $4,050,172 (USD; Tot_Drug_Cst)2020 Drug cost: $4,819,403 (USD; Tot_Drug_Cst)2021 Drug cost: $6,247,731 (USD; Tot_Drug_Cst)2022 Drug cost: $7,083,530 (USD; Tot_Drug_Cst)2023 Drug cost: $6,099,420 (USD; Tot_Drug_Cst)2024 Drug cost: $6,953,743 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152822,049$2,041,746
20162511,872$2,862,723
20172912,675$3,497,528
20183172,663$2,689,742
20193343,034$4,050,172
20203793,276$4,819,403
20213723,280$6,247,731
20223683,488$7,083,530
20233983,209$6,099,420
20244053,578$6,953,743

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$30K$61K2015 Medicare payment: $60,875 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $34,329 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $19,093 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $3,844 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $10,983 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $7,217 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $2,297 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $430 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201513243$60,875
2016N/R168$34,329
2017N/R96$19,093
2018N/R37$3,844
201911152$10,983
2020N/R114$7,217
2021N/R40$2,297
2022N/R12$430
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more374903$92
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's309614$12
80053Blood test, comprehensive group of blood chemicals3991,170$10
36415Insertion of needle into vein for collection of blood sample4481,318$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count4871,588$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LenalidomideLenalidomide561,568$771,897
JakafiRuxolitinib Phosphate591,770$722,818
CalquenceAcalabrutinib Maleate491,470$607,811
RevlimidLenalidomide35903$502,499
PomalystPomalidomide23644$455,145

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$131Rigel Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jijun Liu, MD?

Tedicare shows public-source Medicare data for Jijun Liu, MD (NPI 1043474042), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jijun Liu, MD have ACO affiliation data?

Jijun Liu, MD is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619).

What billing organization is linked to Jijun Liu, MD?

Jijun Liu, MD is linked to ONCOLOGY-HEMATOLOGY ASSOCIATES OF CENTRAL ILLINOIS P C (billing NPI 1801896063) in the available physician profile data.

Does Jijun Liu, MD have Open Payments data?

Jijun Liu, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.